Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Risk Factors for Diabetic Retinopathy and Neural Retinal Degeneration in Youth with Type 1 Diabetes
Author Affiliations & Notes
  • Konstantina Sampani
    Joslin Diabetes Center Beetham Eye Institute, Boston, Massachusetts, United States
    Medicine, Harvard Medical School, Boston, Massachusetts, United States
  • Joyce Keady
    Pediatric, Adolescent and Young Adult Section, Joslin Diabetes and Endocrinology Research Center, Boston, Massachusetts, United States
  • Paolo S Silva
    Joslin Diabetes Center Beetham Eye Institute, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Lori Laffel
    Pediatric, Adolescent and Young Adult Section, Joslin Diabetes and Endocrinology Research Center, Boston, Massachusetts, United States
    Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
  • Lloyd P Aiello
    Joslin Diabetes Center Beetham Eye Institute, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Jennifer K Sun
    Joslin Diabetes Center Beetham Eye Institute, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Konstantina Sampani None; Joyce Keady None; Paolo Silva Optos, Optomed, Hillmro, Code F (Financial Support); Lori Laffel None; Lloyd Aiello Kalvista Novo Nordisk, MantraBio, Ceramedix, Code C (Consultant/Contractor), Optos, Code F (Financial Support), Kalvista, Code I (Personal Financial Interest); Jennifer Sun Optovue, Novo Nordisk, Boehringer Ingelheim, Genentech/Roche, Physical Sciences, Inc, Janssen, Adaptive Sensory Technologies, Boston Micromachines, Code F (Financial Support)
  • Footnotes
    Support  Massachusetts Lions Eye Research Fund, Joslin Diabetes Center [Diabetes Research Center (DRC) Enrichment Core and Clinical Research Center (Grant :P30DK036836)]
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 956. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Konstantina Sampani, Joyce Keady, Paolo S Silva, Lori Laffel, Lloyd P Aiello, Jennifer K Sun; Risk Factors for Diabetic Retinopathy and Neural Retinal Degeneration in Youth with Type 1 Diabetes. Invest. Ophthalmol. Vis. Sci. 2024;65(7):956.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate risk factors associated with diabetic retinopathy and neural retinal layer thickness in youth with type 1 diabetes (T1D).

Methods : Retrospective cross-sectional chart review was conducted of youth (2-21.9 years old) medical records from the Joslin’s Beetham Eye Institute between 2005-2020. Demographic and clinical data were reviewed and collected using standardized forms. SDOCT macula scans were collected for a subset of patients and automated retinal layer segmentation was performed for determining inner and outer layers (IRL, ORL). Multivariate regression analysis was performed to investigate the relationship between demographics, body mass index (BMI), blood pressure (BP), HbA1c, retinal layer cell thickness and volume with presence of DR.

Results : 1359 youth participants (2704 eyes) were included in this study. 49.6% were female, 84.4% white with mean age 13.7±4.3 yrs, T1D duration of 7.0±5.2 yrs, T1D age of onset 7.7±4.7 yrs, HbA1c 8.4±1.3%, BMI 21.9±4.3, systolic BP 109.2±10.4, and diastolic BP 65.8±7.4. Of the eyes in this cohort, 2565 (94.9%) had no DR and 139 (5.14%) had DR [nonproliferative DR:5.1%, proliferative DR:0.04%]. Older age (p<0.001), longer duration of T1D (p<0.001), earlier T1D onset (p<0.04), higher HbA1c (p<0.001), and high systolic and diastolic BP (each p<0.001) were significantly associated with DR presence, and these relationships remained significant when adjusting for age, gender, HbA1c, T1D duration and age at diabetes onset. In 109 eyes (69 subjects) with SDOCT imaging, and no DR, higher HbA1c was significantly associated with thinner central subfield thickness (p = 0.001) and thinner IRL (p=0.004). Higher systolic BP was significantly associated with increased IRL volume (p=0.02). No significant relationship was found between total IRL or ORL thickness and BMI, diastolic BP, or T1D duration.

Conclusions : In this cohort, DR was associated with older age, longer T1D duration, earlier T1D onset and some modifiable risk factors, supporting the fact that control of BP as well as HbA1c is important to prevent DR onset. Moreover, higher HbA1c was correlated with thinner IRL in eyes with no DR, possibly indicating that neurodegeneration is associated with worse glycemic and BP control. These findings highlight the importance of controlling modifiable risk factors to prevent DR and potentially reduce subclinical neural retinal loss in youth with T1D.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×